Langerhans Cell Histiocytosis Enters the Genomics AgeByMichael Jeng, MDFebruary 15th 2016This increased understanding of the pathophysiology of Langerhans cell histiocytosis should help guide treatment and therapies and provides the rationale for using agents effective against myeloid malignancies.